← All organizations

Harrison Clinical Research

For profit

Also known as: Harrison Clinical Research / Clinical Unit, Munich | Harrison Clinical Research Deutschland GmbH (Clinical Unit)

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jun 1, 2013

Acquired by Synteract, Inc. → Syneos Health on Mar 4, 2013

Timeline

1980s

Jun 1, 1987
Harrison Clinical Research— Founded

2010s

Mar 4, 2013
Synteract, Inc.— Acquired By

2020s

Oct 29, 2020
Syneos Health— Now

Drugs by trial phase (11 distinct, 8 trials)

Phase 4 (1 own, 0 via acquisition)

bifidobacterium longum

Phase 3 (1 own, 0 via acquisition)

dimethyl fumarate

Phase 2 (5 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Other trials (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (8)

NCT01793350CollaboratorPhase 1/Phase 2Jun 1, 2013
NCT01726933CollaboratorPhase 3Nov 1, 2012
NCT01591343CollaboratorPhase 2Jun 1, 2012
NCT01408602CollaboratorPhase 2Nov 1, 2011
NCT01375712Overall official - principal investigatorN/AJun 1, 2011
NCT02096302CollaboratorPhase 4Jan 1, 2011
NCT00289510Overall official - principal investigatorPhase 1/Phase 2Jan 1, 2006
NCT00820417Lead sponsorPhase 1Jun 1, 2004

Details

Founded: Munich, DE Jun 1, 1987
Last known activity: Jun 1, 2013

Notes

CRO